Access hsTnI (High Sensitivity Troponin I) Assay

Confidently report accurate results with the first true high-sensitivity troponin I assay cleared by the FDA

Access hsTnI is a true high-sensitivity troponin assay that demonstrates <10% CV at the upper reference limits (URL) for men and women and detects troponin in >50% of the healthy population. In an independent study, the assay detected troponin in >99% of healthy men and women.1 Access hsTnI provides reliable test results that your physicians can count on to make faster and more confident decisions about patient management.

This product may not be available in your country or region at this time. Please contact your Beckman Coulter sales representative or distributor for more information.

Benefits of the Access hsTnI High-sensitivity Troponin I Assay

  • Delivers quality results with a new robust design to minimize the effects of pre-analytical variability and known interferences
  • Demonstrates optimal precision at concentrations ~10x lower than previous generations of assays
  • Enables easier interpretation of test results by using whole-number reporting 
  • Increases testing flexibility as the only high-sensitivity assay to use either plasma or serum samples
  • Accurately identifies ≥94% of true acute myocardial infarction (AMI) patients in as little as one hour after presentation
  • Enables more accurate identification of women with AMI by providing separate sex-specific upper reference limits
  • Provides >99% confidence in ruling out AMI when a patient’s troponin result is below the URL

Webinar Access hsTnI Presentation for Laboratorians

Provide reliable results that physicians can use with confidence to make decisions about patient management. This webinar provides an overview of the clinical guidelines supporting high sensitivity troponin, clinical benefits and key considerations when transitioning to a high sensitivity troponin assay.

Watch now
Medical laboratorian pointing at a tactical diagram for an Access hsTnI implementation guide

Guide Access hsTnI Implementation Guide

Transitioning from contemporary Troponin to High Sensitivity Troponin is a journey. It is important to assess where you are starting as well as your desired destination. Careful planning can help you navigate around potential obstacles, ensuring a successful implementation. This guide has been assembled to serve as a compass, outlining key considerations and insightful guidance from experts in this field.

Laboratorians interpreting elevated cardiac troponin values on a computer monitor

Webinar Access hsTnI Presentation for Clinicians

A successful implementation of high sensitivity troponin includes collaboration with clinicians. This presentation will share fundamental concepts surrounding high sensitivity troponin and how this new test can accelerate a clinician's ability to rule in or rule out myocardial infarction and provide efficiency improvements in cardiac patient management.

Watch now

We offer product training courses and guides to give you the skills and knowledge you need to operate your clinical laboratory instruments.

See all product training courses and guides ›

Brochure Access hsTnI Scientific Literature

Review the latest peer-reviewed analytical and clinical evaluations highlighting the value Access hsTnI can bring to your patients. 


Article The Advantages of High-sensitivity Troponin Tests

High-sensitivity troponin assays detect circulating troponin at lower levels and provide improved diagnostic clarity. Find out how these tests support accelerated decision making and improved care for patients with suspected acute coronary syndrome.

Read more
Access hsTnI Webinar

Webinar High-sensitivity Troponin I: Opportunities in Emergency Care

Learn how high-sensitivity troponin I delivers fast and accurate results that may support rapid rule in/rule out of AMI. When used in conjunction with TIMI risk scores, troponin assays may enable early definitive care and disposition of most ED patients with possible ACS.

View on demand
1Pretorius, C.J., et. al. “A critical evaluation of the Beckman Coulter Access hsTnI: Analytical performance, reference interval and concordance.” Clinical Biochemistry, vol. 55, 2018 May, pp. 49–55. Accessed 22 June 2018.